financetom
Business
financetom
/
Business
/
Mercedes-Benz opens battery research and production centre at Stuttgart headquarters
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Mercedes-Benz opens battery research and production centre at Stuttgart headquarters
Jul 8, 2024 6:31 AM

STUTTGART, July 8 (Reuters) - Mercedes-Benz

inaugurated a development and production centre for battery

cells on Monday at its headquarters in Germany, in a move to

take greater control of the chemical composition and industrial

manufacturing of its batteries.

The location, dubbed "Mercedes-Benz eCampus", will make tens

of thousands of battery cells a year in a 10,000 square metre

factory, with a view to opening a battery test and trial centre

by the end of this year.

Mercedes-Benz is working on lithium ion cells with

high-energy anodes and cobalt-free cathodes, as well as

solid-state technology, which holds the promise of more energy

storage, longer driving ranges and faster charging.

Increasing the energy density of EV batteries is key

particularly for premium carmakers looking to reduce weight and

costs while boosting driving range.

Cell designs developed at the new centre will be shared with

partner companies and incorporated into future battery cells

from suppliers, Mercedes-Benz Chief Technology Officer Markus

Schaefer said.

German Economy Minister Robert Habeck, an advocate of

investment in green technology, attended a tour of the site to

mark its inauguration.

"It is of key importance that Germany and Europe build up

their own capacities and, in particular, their own know-how in

this key technology," Habeck said in a statement.

The luxury carmaker has battery production sites in seven

locations including Germany, the U.S., China, and Poland, and

sources battery cells from suppliers including China's CATL.

It holds a 30% stake in battery cell venture ACC, which last

month paused work on factories in Europe amid slowing demand for

electric vehicles.

It has also invested in Sila Nanotechnologies, which makes

batteries using silicon-based anodes, and signed a supply

agreement with Brandenburg-based Rock Tech Lithium ( RCKTF ) to supply

lithium hydroxide for Mercedes-Benz batteries.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved